Up until now, the reason for the variance in prevalence of IBD between developed and developing countries has been unknown
Psychoneuroendocrinology 31, 10571061.10.1016/j.psyneuen.2006.06.006 248 MuccioliG.LorenziT.LorenziM.GhC.ArnolettiE.RasoG
3 Initially, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) were approved for type-2 diabetes mellitus (T2DM) treatment
Gastrointestinal symptoms including nausea, vomiting, and diarrhea are most common, particularly during dose escalation
This article notes that compounded semaglutide commonly comes at 2 mg/ml, 4 mg/ml or 6 mg/ml, so 1 mg works out to roughly 0.17 ml at 6 mg/ml but about 0.25 ml at 4 mg/ml
IV therapy can help improve metabolism, reduce toxins in the body, and build musclewhich in turn burns fat